{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:54:02Z","timestamp":1787727242416,"version":"build-2784847793"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100009820","name":"Assistance publique-H\u00f4pitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009820","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Chronic hypoparathyroidism (cHP) is a rare endocrine disorder characterized by hypocalcemia secondary to the insufficient secretion of the parathyroid hormone. Despite the good observance of oral treatment with calcium salts and active vitamin D analogs, and even after adding intermittent subcutaneous injections of teriparatide (IST), some patients are still uncontrolled. Previous studies have suggested that continuous subcutaneous administration of teriparatide (CSAT) may be an option in such cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to assess the evolution of biological parameters with CSAT in comparison to previous treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective observational study including all patients who received CSAT from 3 tertiary care centers of the Epi-Hypo study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Blood calcium, phosphate, bone remodeling markers, urine calcium, and the evolution of oral treatment were captured from electronic medical records. Quality of life (QoL) was assessed using the Hypoparathyroid Patient Questionnaire (HPQ28).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty patients were included, 85% were women, and 75% had post-surgery cHP. Total calcium concentration was significantly higher with CSAT than with IST for 73% patients. HPQ28 showed an improvement in three out of the five patients for whom it was assessed. Osteocalcin increased significantly with IST (P = .003), but no difference was observed after initiating CSAT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CSAT may be an option for patients with uncontrolled cHP. Further studies need to investigate bone consequences and better characterize the improvement of QoL among these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf257","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T12:51:41Z","timestamp":1766494301000},"page":"K1-K7","source":"Crossref","is-referenced-by-count":2,"title":["Continuous subcutaneous administration of teriparatide as a therapeutic option in chronic hypoparathyroidism: retrospective study in three tertiary care centers of the epi-hypo study"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0570-749X","authenticated-orcid":false,"given":"Amina","family":"Attia","sequence":"first","affiliation":[{"name":"Service de Pathologies Thyro\u00efdiennes et Tumorales Endocrines, Centre de Comp\u00e9tence des Maladies Rares du M\u00e9tabolisme du Calcium et du Phosphate, Fili\u00e8re Maladies Rares OSCAR, Assistance Publique-H\u00f4pitaux de Paris , H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris 75013 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Bri\u00e8re","sequence":"additional","affiliation":[{"name":"Service de Pathologies Thyro\u00efdiennes et Tumorales Endocrines, Centre de Comp\u00e9tence des Maladies Rares du M\u00e9tabolisme du Calcium et du Phosphate, Fili\u00e8re Maladies Rares OSCAR, Assistance Publique-H\u00f4pitaux de Paris , H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris 75013 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1994-4226","authenticated-orcid":false,"given":"Peter","family":"Kamenicky","sequence":"additional","affiliation":[{"name":"Service D'Endocrinologie et des Maladies de la Reproduction, Centre de R\u00e9f\u00e9rence des Maladies Rares du M\u00e9tabolisme du Calcium et du Phosphate, Fili\u00e8re Maladies Rares OSCAR, H\u00f4pital de Bic\u00eatre , Le Kremlin-Bic\u00eatre 94270 ,","place":["France"]},{"name":"Universit\u00e9 Paris-Saclay, Inserm 1185 , Physiologie et Physiopathologie Endocriniennes , Le Kremlin-Bic\u00eatre 94270 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8630-961X","authenticated-orcid":false,"given":"Anne-Lise","family":"Lecoq","sequence":"additional","affiliation":[{"name":"Service D'Endocrinologie et des Maladies de la Reproduction, Centre de R\u00e9f\u00e9rence des Maladies Rares du M\u00e9tabolisme du Calcium et du Phosphate, Fili\u00e8re Maladies Rares OSCAR, H\u00f4pital de Bic\u00eatre , Le Kremlin-Bic\u00eatre 94270 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8526-8046","authenticated-orcid":false,"given":"Luigi","family":"Maione","sequence":"additional","affiliation":[{"name":"Service D'Endocrinologie et des Maladies de la Reproduction, Centre de R\u00e9f\u00e9rence des Maladies Rares du M\u00e9tabolisme du Calcium et du Phosphate, Fili\u00e8re Maladies Rares OSCAR, H\u00f4pital de Bic\u00eatre , Le Kremlin-Bic\u00eatre 94270 ,","place":["France"]},{"name":"Universit\u00e9 Paris-Saclay, Inserm 1185 , Physiologie et Physiopathologie Endocriniennes , Le Kremlin-Bic\u00eatre 94270 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Houillier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, Inserm U652, D\u00e9partement de Physiologie, European Hospital Georges Pompidou , Paris 75015 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Buffet","sequence":"additional","affiliation":[{"name":"Service de Pathologies Thyro\u00efdiennes et Tumorales Endocrines, Centre de Comp\u00e9tence des Maladies Rares du M\u00e9tabolisme du Calcium et du Phosphate, Fili\u00e8re Maladies Rares OSCAR, Assistance Publique-H\u00f4pitaux de Paris , H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris 75013 ,","place":["France"]},{"name":"Sorbonne Universit\u00e9, Groupe de Recherche Clinique n\u00b016 Tumeurs Thyro\u00efdiennes, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4104-702X","authenticated-orcid":false,"given":"Jean-Philippe","family":"Bertocchio","sequence":"additional","affiliation":[{"name":"Service de Pathologies Thyro\u00efdiennes et Tumorales Endocrines, Centre de Comp\u00e9tence des Maladies Rares du M\u00e9tabolisme du Calcium et du Phosphate, Fili\u00e8re Maladies Rares OSCAR, Assistance Publique-H\u00f4pitaux de Paris , H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris 75013 ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9, Inserm U1333 Sant\u00e9 Orale, FHU-DDS-net, Dental School , Montrouge 92120 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Ghander","sequence":"additional","affiliation":[{"name":"Service de Pathologies Thyro\u00efdiennes et Tumorales Endocrines, Centre de Comp\u00e9tence des Maladies Rares du M\u00e9tabolisme du Calcium et du Phosphate, Fili\u00e8re Maladies Rares OSCAR, Assistance Publique-H\u00f4pitaux de Paris , H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris 75013 ,","place":["France"]},{"name":"Sorbonne Universit\u00e9, Groupe de Recherche Clinique n\u00b016 Tumeurs Thyro\u00efdiennes, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"18","key":"2026011206195549200_lvaf257-B1","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMcp1800213","article-title":"Hypoparathyroidism","volume":"380","author":"Gafni","year":"2019","journal-title":"N Engl J Med."},{"key":"2026011206195549200_lvaf257-B2","doi-asserted-by":"crossref","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","article-title":"Hypoparathyroidism","volume":"3","author":"Mannstadt","year":"2017","journal-title":"Nat rev Dis prim"},{"issue":"10","key":"2026011206195549200_lvaf257-B3","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"12","key":"2026011206195549200_lvaf257-B4","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2026011206195549200_lvaf257-B5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1210\/jc.2009-2682","article-title":"Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism","volume":"96","author":"Rubin","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2026011206195549200_lvaf257-B6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/00000441-199508000-00003","article-title":"Hypoparathyroidism counteracts risk factors for osteoporosis","volume":"310","author":"Touliatos","year":"1995","journal-title":"Am J Med Sci."},{"issue":"5","key":"2026011206195549200_lvaf257-B7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/SLA.0000000000005129","article-title":"Impact of permanent post-thyroidectomy hypoparathyroidism on self-evaluation of quality of life and voice: results from the national QoL-hypopara study","volume":"274","author":"Frey","year":"2021","journal-title":"Ann Surg."},{"issue":"7","key":"2026011206195549200_lvaf257-B8","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/jbmr.2812","article-title":"Concurrent hypoparathyroidism is associated with impaired physical function and quality of life in hypothyroidism","volume":"31","author":"Sikjaer","year":"2016","journal-title":"J Bone Miner Res."},{"issue":"8","key":"2026011206195549200_lvaf257-B9","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1210\/jc.2016-1477","article-title":"Epidemiology and health-related quality of life in hypoparathyroidism in Norway","volume":"101","author":"Astor","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026011206195549200_lvaf257-B10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12020-017-1377-3","article-title":"Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review","volume":"58","author":"B\u00fcttner","year":"2017","journal-title":"Endocrine"},{"key":"2026011206195549200_lvaf257-B11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1530\/eje.0.1460215","article-title":"Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D","volume":"146","author":"Arlt","year":"2002","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2026011206195549200_lvaf257-B12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1210\/jcem-59-3-394","article-title":"Increased renal responses to exogenous parathyroid hormone in postsurgical hypoparathyroidism*","volume":"59","author":"Law","year":"1984","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2026011206195549200_lvaf257-B13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jpeds.2014.04.060","article-title":"Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism","volume":"165","author":"Winer","year":"2014","journal-title":"J Pediatr."},{"issue":"8","key":"2026011206195549200_lvaf257-B14","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/jbmr.1627","article-title":"Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure","volume":"27","author":"Gafni","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"10","key":"2026011206195549200_lvaf257-B15","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1210\/jcem.83.10.5185","article-title":"A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1\u201334 in treatment of hypoparathyroidism","volume":"83","author":"Winer","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2026011206195549200_lvaf257-B16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.4103\/ijem.IJEM_340_16","article-title":"Efficacy of teriparatide in patients with hypoparathyroidism: a prospective, open-label study","volume":"21","author":"Upreti","year":"2017","journal-title":"Indian J Endocrinol Metab."},{"issue":"2","key":"2026011206195549200_lvaf257-B17","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1210\/jc.2017-01471","article-title":"Recombinant human parathyroid hormone effect on health-related quality of life in adults with chronic hypoparathyroidism","volume":"103","author":"Vokes","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2026011206195549200_lvaf257-B18","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1210\/jc.2018-02430","article-title":"Quality of life in hypoparathyroidism improves with rhPTH(1-84) throughout 8 years of therapy","volume":"104","author":"Tabacco","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2026011206195549200_lvaf257-B19","doi-asserted-by":"publisher","first-page":"bvae053","DOI":"10.1210\/jendso\/bvae053","article-title":"Continuous subcutaneous delivery of rhPTH(1-84) and rhPTH(1-34) by pump in adults with hypoparathyroidism","volume":"8","author":"Charoenngam","year":"2024","journal-title":"J Endocr Soc."},{"issue":"2","key":"2026011206195549200_lvaf257-B20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1515\/cclm-2019-0568","article-title":"Calcium state estimation by total calcium: the evidence to end the never-ending story","volume":"58","author":"Pekar","year":"2020","journal-title":"Clin Chem Lab Med."},{"issue":"11","key":"2026011206195549200_lvaf257-B21","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1210\/jc.2011-1359","article-title":"Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism","volume":"96","author":"Linglart","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2026011206195549200_lvaf257-B22","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5593653","article-title":"Desperate times call for desperate measures: use of continuous subcutaneous 1-34 PTH infusion for postsurgical hypoparathyroidism","volume":"2021","author":"Haider","year":"2021","journal-title":"Case Rep Endocrinol"},{"issue":"1","key":"2026011206195549200_lvaf257-B23","doi-asserted-by":"publisher","first-page":"5593653","DOI":"10.1155\/2021\/5593653","article-title":"Desperate times call for desperate measures: use of continuous subcutaneous 1-34 PTH infusion for postsurgical hypoparathyroidism","volume":"2021","author":"Haider","year":"2021","journal-title":"Case Rep Endocrinol."},{"issue":"2","key":"2026011206195549200_lvaf257-B24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12020-023-03355-1","article-title":"Continuous subcutaneous rhPTH infusion for managing difficult chronic hypoparathyroidism. A systematic review","volume":"81","author":"Gamarra","year":"2023","journal-title":"Endocrine"},{"issue":"2","key":"2026011206195549200_lvaf257-B25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1210\/jc.2011-1908","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2026011206195549200_lvaf257-B26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1530\/EJE-18-0580","article-title":"Long-term complications in patients with chronic hypoparathyroidism: a cross-sectional study","volume":"180","author":"David","year":"2019","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2026011206195549200_lvaf257-B27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.18632\/aging.206177","article-title":"The comparison of serum bone-turnover markers in different stage of chronic kidney disease and the associated impact of intradialytic cycling in patients with end-stage renal disease","volume":"17","author":"Hou","year":"2025","journal-title":"Aging (Albany NY)."},{"issue":"3","key":"2026011206195549200_lvaf257-B28","doi-asserted-by":"crossref","first-page":"ziaf011","DOI":"10.1093\/jbmrpl\/ziaf011","article-title":"Adaptation and validation of the French version of the Hypoparathyroid Patient Questionnaire 28 (HPQ28) in the ComPaRe-Epi-Hypo e-cohort.","volume":"9","author":"Bertocchio","year":"2025","journal-title":"JBMR plus"},{"issue":"1","key":"2026011206195549200_lvaf257-B29","doi-asserted-by":"crossref","first-page":"e10245","DOI":"10.1002\/jbm4.10245","article-title":"The HPQ-development and first administration of a questionnaire for Hypoparathyroid patients","volume":"4","author":"Wilde","year":"2020","journal-title":"JBMR plus"},{"issue":"20","key":"2026011206195549200_lvaf257-B30","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"2026011206195549200_lvaf257-B31","doi-asserted-by":"publisher","first-page":"e210350","DOI":"10.1530\/EC-21-0350","article-title":"Practice patterns for chronic hypoparathyroidism: data from patients and physicians in France","volume":"11","author":"Bertocchio","year":"2022","journal-title":"Endocr Connect."},{"issue":"2","key":"2026011206195549200_lvaf257-B32","first-page":"391","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.","volume":"97","author":"Winer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026011206195549200_lvaf257-B33","doi-asserted-by":"crossref","first-page":"e931739","DOI":"10.12659\/AJCR.931739","article-title":"Continuous Teriparatide Treatment in Chronic Hypoparathyroidism: A Case Report.","volume":"22","author":"Saraiva","year":"2021","journal-title":"Am J Case Rep"},{"issue":"6","key":"2026011206195549200_lvaf257-B34","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"issue":"8","key":"2026011206195549200_lvaf257-B35","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1210\/jc.2016-1477","article-title":"Epidemiology and health-related quality of life in hypoparathyroidism in Norway","volume":"101","author":"Astor","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026011206195549200_lvaf257-B36","doi-asserted-by":"publisher","first-page":"1464515","DOI":"10.3389\/fendo.2024.1464515","article-title":"Prevalence of chronic postsurgical hypoparathyroidism not adequately controlled: an analysis of a nationwide cohort of 337 patients","volume":"15","author":"D\u00edez","year":"2024","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"2026011206195549200_lvaf257-B37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jbmr.4726","article-title":"Efficacy and safety of parathyroid hormone replacement with TransCon PTH in hypoparathyroidism: 26-week results from the phase 3 PaTHway trial","volume":"38","author":"Khan","year":"2020","journal-title":"J Bone Miner Res."},{"key":"2026011206195549200_lvaf257-B38"},{"issue":"2","key":"2026011206195549200_lvaf257-B39","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-21-1044","article-title":"European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders (PARAT 2021)","volume":"186","author":"Bollerslev","year":"2022","journal-title":"Eur J Endocrinol."},{"issue":"Supplement_1","key":"2026011206195549200_lvaf257-B40","doi-asserted-by":"publisher","first-page":"bvad114.562","DOI":"10.1210\/jendso\/bvad114.562","article-title":"OR23-04 treatment of chronic hypoparathyroidism with eneboparatide (AZP-3601), A novel PTH 1 receptor agonist: results from A phase 2 trial","volume":"7","author":"Kamenicky","year":"2023","journal-title":"J Endocr Soc."}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf257\/66123437\/lvaf257.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/1\/K1\/66123437\/lvaf257.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/1\/K1\/66123437\/lvaf257.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T11:30:03Z","timestamp":1768217403000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/194\/1\/K1\/8404128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf257","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,24]]}}}